UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.823

Sortiert nach

Boron-Doped Graphene Quantum Dots for Selective Glucose Sensing Based on the “Abnormal” Aggregation-Induced Photoluminescence Enhancement

Analytical chemistry (Washington), 2014-05, Vol.86 (9), p.4423-4430

2014

Volltextzugriff (PDF)

Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19

Journal of medical virology, 2020-09, Vol.92 (9), p.1533-1541

2020

Volltextzugriff (PDF)

Gain Enhancement of Horn Antenna Using a Metal Lens

IEEE transactions on antennas and propagation, 2023-02, Vol.71 (2), p.1337-1349

2023

Volltextzugriff (PDF)

Wideband High-Gain Omnidirectional Biconical Antenna for Millimeter-Wave Applications

IEEE transactions on antennas and propagation, 2023-01, Vol.71 (1), p.58-66

2023

Volltextzugriff (PDF)

Genome of Laudakia sacra Provides New Insights into High-Altitude Adaptation of Ectotherms

International journal of molecular sciences, 2022-09, Vol.23 (17), p.10081

2022

Volltextzugriff (PDF)

A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models

Oncotarget, 2018-12, Vol.9 (98), p.37080-37096

2018

Volltextzugriff (PDF)

Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan) in Healthy Subjects

Journal of clinical pharmacology, 2018-08, Vol.58 (8), p.1074-1083

2018

Volltextzugriff (PDF)

The technology of artificial pneumoperitoneum CT and its application in diagnosis of abdominal adhesion

Scientific reports, 2021-10, Vol.11 (1), p.20785-20785, Article 20785

2021

Volltextzugriff (PDF)

The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer

Cancer chemotherapy and pharmacology, 2018-03, Vol.81 (3), p.497-503

2018

Volltextzugriff (PDF)

Pharmacokinetics of Rolapitant in Patients With Mild to Moderate Hepatic Impairment

Journal of clinical pharmacology, 2018-05, Vol.58 (5), p.686-693

2018

Volltextzugriff (PDF)

Pharmacokinetic Interactions of Rolapitant With Cytochrome P450 3A Substrates in Healthy Subjects

Journal of clinical pharmacology, 2019-04, Vol.59 (4), p.488-499

2019

Volltextzugriff (PDF)

Bioequivalence of Intravenous and Oral Rolapitant: Results From a Randomized, Open‐Label Pivotal Study

Journal of clinical pharmacology, 2017-12, Vol.57 (12), p.1600-1606

2017

Volltextzugriff (PDF)

Phase I Pharmacokinetic Study of Niraparib in Chinese Patients with Epithelial Ovarian Cancer

The oncologist (Dayton, Ohio), 2020-01, Vol.25 (1), p.19-e10

2020

Volltextzugriff (PDF)

Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment

Cancer chemotherapy and pharmacology, 2021-11, Vol.88 (5), p.825-836

2021

Volltextzugriff (PDF)

Gemological and Mineralogical Studies of Greenish Blue Apatite in Madagascar

Crystals (Basel), 2022-08, Vol.12 (8), p.1067

2022

Volltextzugriff (PDF)

Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma

Journal of hepatology, 2021-04, Vol.74 (4), p.838-849

2021

Volltextzugriff (PDF)

Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers

Journal of clinical pharmacology, 2018-02, Vol.58 (2), p.202-211

2018

Volltextzugriff (PDF)

Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects

Supportive care in cancer, 2019-03, Vol.27 (3), p.819-827

2019

Volltextzugriff (PDF)

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

British journal of cancer, 2019-07, Vol.121 (2), p.131-138

2019

Volltextzugriff (PDF)

Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells

International journal of cancer, 2017-10, Vol.141 (7), p.1445-1457

2017

Volltextzugriff (PDF)

Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma

PloS one, 2014-01, Vol.9 (1), p.e85592-e85592

2014

Volltextzugriff (PDF)

Absorption, metabolism, and excretion of the antiemetic rolapitant, a selective neurokinin-1 receptor antagonist, in healthy male subjects

Investigational new drugs, 2019-02, Vol.37 (1), p.139-146

2019

Volltextzugriff (PDF)

Neuron‐specific deletion of presenilin enhancer2 causes progressive astrogliosis and age‐related neurodegeneration in the cortex independent of the Notch signaling

CNS neuroscience & therapeutics, 2021-02, Vol.27 (2), p.174-185

2021

Volltextzugriff (PDF)

Population Pharmacokinetics of Rolapitant in Patients With Chemotherapy‐Induced Nausea and Vomiting

Clinical pharmacology in drug development, 2019-10, Vol.8 (7), p.850-860

2019

Volltextzugriff (PDF)

A multiple genomic data fused SF2 prediction model, signature identification, and gene regulatory network inference for personalized radiotherapy

Technology in cancer research & treatment, 2020, Vol.19, p.1533033820909112-1533033820909112

2020

Volltextzugriff (PDF)

1 – 25 von 1.823

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.376)
Mit Volltextzugriff
(1.603)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(979)
Life Sciences & Biomedicine
(494)
Humans
(369)
Physical Sciences
(349)
Technology
(255)
Male
(250)
Female
(214)
Chemistry
(198)
Middle Aged
(166)
Adult
(151)
Engineering
(140)
Animals
(135)
Physics
(134)
Materials Science
(133)
Aged
(114)
Materials Science, Multidisciplinary
(108)
Chemistry, Multidisciplinary
(98)
General & Internal Medicine
(78)
Medicine, General & Internal
(77)
Pharmacology & Pharmacy
(71)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(29)

Menü

Weitere Dienste

Einstellungen

Boron-Doped Graphene Quantum Dots for Selective Glucose Sensing Based on the “Abnormal” Aggregation-Induced Photoluminescence Enhancement

Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19

Gain Enhancement of Horn Antenna Using a Metal Lens

Wideband High-Gain Omnidirectional Biconical Antenna for Millimeter-Wave Applications

Genome of Laudakia sacra Provides New Insights into High-Altitude Adaptation of Ectotherms

A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models

Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan) in Healthy Subjects

The technology of artificial pneumoperitoneum CT and its application in diagnosis of abdominal adhesion

The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer

Pharmacokinetics of Rolapitant in Patients With Mild to Moderate Hepatic Impairment

Pharmacokinetic Interactions of Rolapitant With Cytochrome P450 3A Substrates in Healthy Subjects

Bioequivalence of Intravenous and Oral Rolapitant: Results From a Randomized, Open‐Label Pivotal Study

Phase I Pharmacokinetic Study of Niraparib in Chinese Patients with Epithelial Ovarian Cancer

Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment

Gemological and Mineralogical Studies of Greenish Blue Apatite in Madagascar

Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma

Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers

Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells

Decreased expression of PTPN12 correlates with tumor recurrence and poor survival of patients with hepatocellular carcinoma

Absorption, metabolism, and excretion of the antiemetic rolapitant, a selective neurokinin-1 receptor antagonist, in healthy male subjects

Neuron‐specific deletion of presenilin enhancer2 causes progressive astrogliosis and age‐related neurodegeneration in the cortex independent of the Notch signaling

Population Pharmacokinetics of Rolapitant in Patients With Chemotherapy‐Induced Nausea and Vomiting

A multiple genomic data fused SF2 prediction model, signature identification, and gene regulatory network inference for personalized radiotherapy

Suchergebnisse filtern